Welcome to our dedicated page for Kemper SEC filings (Ticker: KMPR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Kemper Corporation (NYSE: KMPR) SEC filings page on Stock Titan provides centralized access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a diversified insurance group with Specialty Property & Casualty and Life Insurance segments, Kemper uses its filings to report financial results, capital structure, governance decisions, and executive compensation arrangements.
Investors can review Form 10-K annual reports and Form 10-Q quarterly reports to see segment-level data for personal and commercial automobile insurance and life-related products, including earned premiums, net investment income, policyholders’ benefits, insurance reserves, and shareholders’ equity. These filings also present non-GAAP measures such as adjusted consolidated net operating income, along with reconciliations and discussions of catastrophe losses and underlying combined ratios.
Form 8-K current reports are particularly important for KMPR, as they disclose material events such as quarterly earnings releases, the availability of investor supplements and earnings call presentations, leadership transitions, retention awards for senior executives, and separation and release agreements for departing officers. Recent 8-K and 8-K/A filings detail the appointment and compensation of an interim chief executive officer, retention awards in the form of restricted stock units, and severance and benefit terms for a former executive vice president and chief claims officer.
Through Stock Titan, these filings are updated in near real time from the SEC’s EDGAR system and are paired with AI-powered summaries that highlight key points in plain language. Users can quickly identify how Kemper’s capital management actions, such as debt repayment or share repurchases, appear in the footnotes and MD&A, and how rating agency information and risk factors are reflected in the 10-K and 10-Q disclosures.
In addition to periodic and current reports, investors can use this page to locate information relevant to insider and executive equity awards, as described in compensation-related 8-K items, and to track how governance and compensation structures evolve alongside Kemper’s insurance operations. This makes the KMPR filings page a practical starting point for analyzing the company’s financial condition, risk profile, and corporate governance record.
A shareholder of KMPB has filed a Form 144 notice to sell 96,235 shares of common stock through UBS Financial Services on or about 12/12/2025, with an indicated aggregate market value of $3,945,635. The filing states that there were 58,546,860 shares outstanding at the time, providing a baseline for the size of the planned sale. The shares to be sold were acquired on 12/12/2025 via a stock option exercise from the issuer, paid for in cash.
Kemper Corp’s executive vice president and chief financial officer received a new equity award. On 12/01/2025, the officer acquired 19,056 shares of Kemper common stock in the form of restricted stock units at a price of $40.67 per share. Following this grant, the officer beneficially owns 19,056 shares directly.
The award was granted under the Kemper Corporation Second Amended and Restated 2023 Omnibus Plan and is subject to forfeiture and other restrictions until it vests according to the plan and the related award agreement.
Kemper Corp reported an insider equity award for one of its senior executives. An executive serving as EVP and Chief Operations & Technology Officer received 13,524 shares of common stock on 12/01/2025 at a price of $40.67 per share. After this transaction, the insider beneficially owned 18,344 shares, held directly.
The filing notes that this grant represents an award of restricted stock units under the Kemper Corporation Second Amended and Restated 2023 Omnibus Plan, which are subject to forfeiture and other restrictions until they vest according to the plan and award agreement.
Kemper Corp executive EVP, President, Kemper Auto reported a stock-based compensation award. On 12/01/2025, the insider acquired 19,056 shares of common stock at a price of $40.67 per share, shown as an acquisition transaction. Following this award, the insider beneficially owns 47,502 shares directly.
The footnote explains this was an award of restricted stock units under the Kemper Corporation Second Amended and Restated 2023 Omnibus Plan, which are subject to forfeiture and other restrictions until they vest according to the plan and the related award agreement. This filing reflects routine equity compensation rather than an open-market purchase or sale.
Kemper Corporation reported an equity award to a senior executive. On 12/01/2025, the EVP and President of Kemper Life received 12,295 shares of common stock, reported as an acquisition at a reference price of $40.67 per share. These shares are described as restricted stock units granted under the Kemper Corporation Second Amended and Restated 2023 Omnibus Plan and are subject to forfeiture and other restrictions until they vest according to the plan and award agreement. Following this grant, the executive beneficially owns 22,245 shares of Kemper common stock held directly.
The Vanguard Group has reported a significant ownership position in Kemper Corp common stock. As of the event date of 11/28/2025, Vanguard beneficially owned 6,032,648 shares, representing 10.3% of Kemper’s common stock.
Vanguard reports no sole voting power over these shares, with 391,279 shares subject to shared voting power. It has sole dispositive power over 5,566,978 shares and shared dispositive power over 465,670 shares. The position is held on behalf of Vanguard’s clients, including registered investment companies and other managed accounts, and no single other client has more than a 5% interest in the securities. Vanguard also certifies that the shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Kemper Corp.
Kemper Corp (KMPR) insider activity: A company director reported an open-market purchase of common stock. On 11/10/2025, the director bought 25,000 shares at a price of $36.82 per share. Following this transaction, the director directly owns 48,152 shares.
This is a routine Form 4 disclosure of insider buying and reflects a change in the director’s personal holdings.
Kemper Corporation disclosed RSU retention awards for senior executives to support leadership continuity. The Committee approved grants for three named officers: Bradley T. Camden ($775,000), John M. Boschelli ($675,000), and Matthew A. Hunton ($775,000). Fifty percent vests on the first anniversary of the grant date and the remainder on the second anniversary, each subject to continued service. The grant date is expected to be the first trading day in December 2025.
Kemper Corporation filed an amendment to disclose compensation terms for Interim CEO C. Thomas Evans, Jr. Effective October 14, 2025, his annualized base salary is $800,000 during his interim term.
He will also receive a restricted stock unit award with a grant date fair value of $1,000,000. 50% of the award vests on the one-year anniversary of the grant date and the remaining 50% vests on the two-year anniversary, in each case subject to continued service. The grant date is expected to be the first trading day in December 2025.
Kemper Corporation reported Q3 2025 results showing a net loss of $21.0M (diluted EPS $(0.34)) on total revenue of $1,239.7M, compared with net income of $73.7M a year ago. The quarter was pressured by higher policyholders’ benefits and incurred losses and LAE of $924.6M versus $769.3M in Q3 2024.
Year to date, net income was $151.3M. Operating cash flow strengthened to $409.5M for the nine months, supporting debt repayment of $450.0M and common stock repurchases of $251.3M. Interest expense decreased to $9.1M in the quarter. Shareholders’ equity was $2,721.6M, and accumulated other comprehensive loss improved.
Insurance reserves rose to $6,123.6M. Shares outstanding were 60.2M as of September 30, 2025; 58,546,860 were outstanding as of November 3, 2025.